Stryker Boosts Innovation: R&D Expands with Medical Device Testing Facility

Research and development (R&D) play a crucial role in improving the health and well-being of patients all over the world. It leads to the development of new technologies and procedures that empower healthcare professionals to deliver for their patients. Stryker’s R&D facility in India, Stryker’s Global Technology Centre (SGTC), recently expanded to accommodate rigorous life cycle testing of medical devices, including additional highly skilled engineers and microbiologists to conduct prototyping and product development testing in addition to expanded microbiology development testing.

• At Stryker, our commitment to industry-leading quality standards starts with our product development process, where we design for quality, manufacturability, serviceability, product security and reliability.
• Stryker established its first R&D facility in India more than 15 years ago and today the company’s footprint continues to expand to meet the healthcare needs of care teams all over the world.
• In 2022, Stryker strengthened its R&D capabilities by opening a new research and development facility, Stryker’s Global Technology Centre (SGTC), in India to help accelerate innovation globally.
• The SGTC facility has recently expanded to accommodate rigorous life cycle testing of medical devices, including additional highly skilled engineers and microbiologists to conduct prototyping and product development testing in addition to expanded pre-clinical microbiology testing.

Why it’s Important

The expansion allows Stryker to add more capabilities and accommodate for the future growth of R&D across a variety of procedures. Ram Rangarajan, Vice President of Stryker Global Technology Center says, “This new lab represents our commitment to developing medical technologies that improve patient outcomes and comply with the highest regulatory standards.”

Original source here.